SCLXW Scilex Holding Company - Warrant
$0,14
Fiyat · Haz 18, 2026
Temel veriler itibarıyla Nis 10, 2026
52 Haftlık Aralık
$0–$0
36% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-0.0
ROE
186.8%
Net Kâr Marjı
-1236.4%
SCLXW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.14
Piyasa Değeri
$1M
P/E (TTM)
-0.0
EPS (TTM)
$-36.48
Gelir (TTM)
$30M
Temettü Verimi
—
ROE
186.8%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
SCLXW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$30M
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-36.48
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$4M
2022-12-31
→
2025-12-31
Marjlar
-1236.4%
2025-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
SCLXW
Akran Ortalaması
P/E (TTM)
-0.0
—
P/S (TTM) (F/S (TTM))
0.0
—
P/B (F/D)
-0.0
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
0.4
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
SCLXW
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
415.8%
—
Operating Margin (Faaliyet Kâr Marjı)
-1143.7%
—
Net Profit Margin (Net Kâr Marjı)
-1236.4%
—
ROA
-163.4%
—
ROE
186.8%
—
ROIC
166.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
SCLXW
Akran Ortalaması
Current Ratio (Cari Oran)
0.1
—
Quick Ratio (Cari Oran)
0.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
SCLXW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-46.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-7.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
5.1%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
SCLXW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $30M | $57M | $47M | $38M | $31M | $24M | |
| Cost of Revenue | $96M | $111M | $16M | $11M | $4M | $2M | |
| Gross Profit | $126M | $167M | · | · | · | · | |
| R&D Expense | $21M | $10M | $13M | $9M | $9M | $10M | |
| SG&A Expense | $267M | $119M | $120M | $65M | $51M | $43M | |
| Operating Income | $-346M | $-83M | $-105M | $-51M | $-36M | $-35M | |
| Interest Expense | · | · | $1M | $10M | $12M | $13M | |
| Other Non-op | $-28M | $11M | $-9M | $27M | $-53M | $-12M | |
| Pretax Income | $-374M | $-73M | $-114M | $-23M | $-88M | $-48M | |
| Income Tax | $26.0K | $-1.0K | $13.0K | $4.0K | $5.0K | $-53.0K | |
| Net Income | $-374M | $-73M | $-114M | $-23M | $-88M | $-48M | |
| EPS (Basic) | $-36.48 | $-7.24 | $-1.28 | $-0.17 | $-0.67 | $-0.36 | |
| EPS (Diluted) | $-36.48 | $-8.05 | $-1.28 | $-0.17 | $-0.67 | $-0.36 | |
| Shares (Basic) | 11,034 | 10,061 | 130,298,000 | 134,226,000 | 132,858,000 | 132,891 | |
| Shares (Diluted) | 11,034 | 10,145 | 130,298,000 | 134,226,000 | 132,858,000 | 132,891 | |
| EBITDA | $-341M | · | $-101M | $-47M | $-1M | · |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $3M | $4M | $2M | $4M | $30.5K | |
| Short-term Investments | · | · | · | · | $303.8K | · | |
| Receivables | $15M | $26M | $35M | $21M | $14M | · | |
| Inventory | $5M | $2M | $4M | $1M | $3M | · | |
| Prepaid Expense | · | · | · | · | $4.5K | · | |
| Current Assets | $38M | $42M | $47M | $30M | $23M | $30.5K | |
| PP&E (Net) | $14M | $708.0K | $722.0K | $772.0K | $805.0K | · | |
| PP&E (Gross) | $14M | $772.0K | $780.0K | $939.0K | $932.0K | · | |
| Accum. Depreciation | $321.0K | $64.0K | $58.0K | $167.0K | $127.0K | · | |
| Goodwill | $13M | $13M | $13M | $13M | $13M | · | |
| Intangibles | $59M | $32M | $36M | $41M | $39M | · | |
| Total Assets | $365M | $93M | $101M | $87M | $78M | $199.5K | |
| Accounts Payable | $86M | $53M | $41M | $8M | $4M | · | |
| Short-term Debt | · | · | · | $0 | $38M | · | |
| Current Liabilities | $484M | $260M | $250M | $45M | $169M | $180.8K | |
| Capital Leases | $13M | $2M | $2M | $665.0K | $1M | · | |
| Other Non-current Liabilities | $174.0K | $155.0K | $179.0K | $163.0K | $0 | · | |
| Total Liabilities | $577M | $286M | $274M | $50M | $302M | $180.8K | |
| Long-term Debt | · | · | · | $0 | $72M | · | |
| Total Debt | · | · | · | $0 | · | · | |
| Common Stock | $1.0K | $1.0K | $16.0K | $14.0K | $13.0K | $345 | |
| Paid-in Capital | $797M | $455M | $408M | $412M | $129M | $24.7K | |
| Retained Earnings | $-922M | $-563M | $-490M | $-376M | $-353M | $-6.3K | |
| Treasury Stock | $77M | $91M | $91M | $0 | · | · | |
| AOCI | $-6M | $6M | $0 | · | · | · | |
| Stockholders' Equity | $-208M | $-193M | $-173M | $36M | $-224M | $18.7K | |
| Liabilities + Equity | $365M | $93M | $101M | $87M | $78M | $199.5K | |
| Shares Outstanding | 7,033,004 | 5,235,377 | 100,015,665 | 141,348,856 | 132,858,484 | 3,450,000 |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $5M | $4M | $4M | $4M | $4M | $4M | |
| Stock-based Comp | $15M | $16M | $15M | $5M | $6M | $5M | |
| Deferred Tax | $14M | $-19M | $-28M | $-12M | $-15M | $-4M | |
| Amort. of Intangibles | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | $344M | · | $103M | $5M | · | · | |
| Operating Cash Flow | $4M | $19M | $-21M | $-21M | $-29M | $-31M | |
| CapEx | $133.0K | $0 | $30.0K | $7.0K | $0 | $25.0K | |
| Investing Cash Flow | $4M | $-3M | $-330.0K | $-2M | $0 | $-25.0K | |
| Stock Issued | · | · | $35M | $0 | $0 | · | |
| Net Stock Activity | · | · | $35M | · | $136M | $25.0K | |
| Dividends Paid | · | $9M | $9M | · | · | · | |
| Financing Cash Flow | $-5M | $-18M | $24M | $21M | $28M | $-19M | |
| Net Change in Cash | $2M | $-1M | $3M | $-2M | $-501.0K | $-51M | |
| Taxes Paid | $21.0K | · | · | · | · | · | |
| Free Cash Flow | $4M | · | $-21M | $-21M | · | · | |
| Levered FCF | · | · | $-22M | $-31M | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 415.8% | · | · | · | · | · | |
| Operating Margin | -1143.7% | · | -225.6% | -133.1% | · | · | |
| Net Margin | -1236.4% | · | -244.6% | -61.4% | · | · | |
| Pretax Margin | -1236.3% | · | -244.6% | -61.4% | · | · | |
| EBITDA Margin | -1128.4% | · | -216.7% | -122.7% | · | · | |
| ROA | -163.4% | · | -121.7% | -28.4% | 1.1% | -6.3% | |
| ROE | 186.8% | · | 167.3% | -183.4% | -8.5% | -91.5% | |
| ROIC | 166.5% | · | 61.0% | -139.8% | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | · | 0.2 | 0.7 | 2.5 | · | |
| Quick Ratio | 0.0 | · | 0.2 | 0.5 | 3.9 | 0.2 | |
| Debt / Equity | · | · | · | 0.0 | · | · | |
| Interest Coverage | · | · | -98.7 | -5.3 | -550.7 | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.5 | 0.5 | · | · | |
| Inventory Turnover | 26.7 | · | 5.6 | 5.5 | · | · | |
| Receivables Turnover | 1.5 | · | 1.7 | 2.1 | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.5% | 21.1% | 22.9% | 21.4% | 32.9% | · | |
| Revenue CAGR 3Y | -7.3% | 21.8% | 25.7% | · | · | · | |
| Revenue CAGR 5Y | 5.1% | · | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $30M | $57M | $47M | $38M | $31M | $24M | |
| Net Income TTM | $-374M | $-73M | $-114M | $-23M | $-88M | $-48M | |
| Market Cap | $1M | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | |
| P/S | 0.0 | · | · | · | · | · | |
| P/B | -0.0 | · | · | · | · | · | |
| P / Cash Flow | 0.4 | · | · | · | · | · | |
| P / FCF | 0.4 | · | · | · | · | · | |
| Earnings Yield | -18240.0% | · | · | · | · | · | |
| Payout Ratio | · | · | -7.6% | · | · | · | |
| Annual Payout | · | $9M | $9M | · | · | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $11M | $10M | $5M | $15M | $14M | $16M | $11M | $13M | $10M | $13M | $11M | $12M | $11M | $8M | $7M | |
| Cost of Revenue | $88M | $3M | $3M | $1M | $99M | $4M | $4M | $4M | $5M | $3M | $4M | $4M | $5M | $4M | $2M | $1M | |
| R&D Expense | $8M | $4M | $6M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $1M | $3M | $3M | |
| SG&A Expense | $30M | $189M | $20M | $28M | $35M | $30M | $25M | $29M | $24M | $40M | $27M | $29M | $24M | $16M | $14M | $11M | |
| Operating Income | $-111M | $-187M | $-21M | $-28M | $-28M | $-20M | $-16M | $-19M | $-18M | $-39M | $-23M | $-25M | $-20M | $-11M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | $531.0K | · | $513.0K | · | $-1.0K | $8M | $2M | $8.3K | $7.5K | |
| Other Non-op | $65M | $-71M | $-24M | $2M | $22M | $16M | $-22M | $-5M | $-12M | $3M | $-5.0K | $-1.0K | $-4M | $32M | $-4M | $3M | |
| Pretax Income | $-46M | $-258M | $-44M | · | $-6M | $-4M | $-38M | $-24M | $-21M | $-36M | $-27M | $-31M | $-18M | $21M | $-18M | $-9M | |
| Income Tax | $6.0K | $1.0K | $19.0K | · | $-1.0K | $0 | $0 | $0 | $8.0K | $0 | $-3.0K | $8.0K | $40.0K | $-11.0K | $-28.0K | $3.0K | |
| Net Income | $-46M | $-258M | $-44M | $-26M | $-6M | $-4M | $-38M | $-24M | $-21M | $-36M | $-27M | $-31M | $-18M | $22M | $-18M | $-9M | |
| EPS (Basic) | $-4.63 | $-22.17 | $-7.42 | $-2.26 | $9.34 | $-0.58 | $-7.67 | $-8.33 | $-0.24 | $-0.63 | $-0.19 | $-0.22 | $-0.13 | $0.16 | $-0.13 | $-0.07 | |
| EPS (Diluted) | $-4.63 | $-22.17 | $-7.42 | $-2.26 | $8.53 | $-0.58 | $-7.67 | $-8.33 | $-0.24 | $-0.63 | $-0.19 | $-0.22 | $-0.13 | $0.16 | $-0.13 | $-0.07 | |
| Shares (Basic) | -23,730 | 11,604 | 11,595 | 11,565 | -5,323 | 7,557 | 4,901 | 2,926 | -12,609,468 | 139,808 | 142,626,000 | 141,660 | -264,920,000 | 133,060,000 | 133,060,000 | 133,026,000 | |
| Shares (Diluted) | -23,730 | 11,604 | 11,595 | 11,565 | -5,239 | 7,557 | 4,901 | 2,926 | -12,609,468 | 139,808 | 142,626,000 | 141,660 | -265,143,000 | 133,283,000 | 133,060,000 | 133,026,000 | |
| EBITDA | · | $-187M | $-21M | $-27M | · | $-20M | · | $-18M | · | $-39M | $-23M | $-24M | · | $-657.7K | $-1M | $-320.4K |
Bilanço 25
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $878.0K | $4M | $6M | $3M | $77.0K | · | $2M | $4M | $2M | $34M | $5M | $2M | $35.0K | $351.3K | $127.4K | |
| Receivables | $15M | $12M | $17M | $11M | $26M | $32M | · | $30M | $35M | $16M | $28M | $19M | $21M | · | · | · | |
| Inventory | $5M | $1M | $3M | $3M | $2M | $2M | · | $3M | $4M | $4M | $3M | $2M | $1M | · | · | · | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $130.8K | $261.6K | $396.9K | |
| Current Assets | $38M | $16M | $34M | $29M | $42M | $40M | · | $38M | $47M | $25M | $69M | $31M | $30M | $165.7K | $612.8K | $524.3K | |
| PP&E (Net) | $14M | $703.0K | $705.0K | $707.0K | $708.0K | $711.0K | · | $718.0K | $722.0K | $769.0K | $760.0K | $762.0K | $772.0K | · | · | · | |
| PP&E (Gross) | $14M | $772.0K | $772.0K | $772.0K | $772.0K | $753.0K | · | $753.0K | $780.0K | $968.0K | $947.0K | $939.0K | $939.0K | · | · | · | |
| Accum. Depreciation | $321.0K | $69.0K | $67.0K | $65.0K | $64.0K | $42.0K | · | $35.0K | $58.0K | $199.0K | $187.0K | $177.0K | $167.0K | · | · | · | |
| Goodwill | $13M | $13M | $13M | $13M | $13M | $13M | · | $13M | $13M | $13M | $13M | $13M | $13M | · | · | · | |
| Intangibles | $59M | $30M | $31M | $31M | $32M | $33M | · | $35M | $36M | $38M | $39M | $40M | $41M | · | · | · | |
| Total Assets | $365M | $276M | $84M | $79M | $93M | $100M | · | $91M | $101M | $81M | $126M | $86M | $87M | $101M | $142M | $141M | |
| Accounts Payable | $86M | $67M | $59M | $57M | $53M | $43M | · | $42M | $41M | $33M | $11M | $10M | $8M | $809.3K | $598.6K | $41.0K | |
| Accrued Liabilities | · | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $484M | $359M | $306M | $276M | $260M | $282M | · | $253M | $250M | $229M | $104M | $65M | $45M | $809.3K | $598.6K | $41.0K | |
| Capital Leases | $13M | $918.0K | $1M | $1M | $2M | $2M | · | $2M | $2M | $2M | $3M | $461.0K | $665.0K | · | · | · | |
| Other Non-current Liabilities | $174.0K | $169.0K | $165.0K | $155.0K | $155.0K | $155.0K | · | $182.0K | $179.0K | $173.0K | $169.0K | $168.0K | $163.0K | · | · | $76.8K | |
| Total Liabilities | $577M | $456M | $333M | $290M | $286M | $312M | · | $281M | $274M | $243M | $116M | $75M | $50M | $12M | $53M | $11M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $19.0K | · | $17.0K | $16.0K | $15.0K | $15.0K | $15.0K | $14.0K | $345 | $345 | $345 | |
| Paid-in Capital | $797M | $785M | $453M | $448M | $455M | $431M | · | $415M | $408M | $397M | $444M | $418M | $412M | · | · | · | |
| Retained Earnings | $-922M | $-889M | $-631M | $-589M | $-563M | $-557M | · | $-515M | $-490M | $-469M | $-433M | $-407M | $-376M | $-12M | $-11M | $-11M | |
| Treasury Stock | $77M | $77M | $77M | $77M | $91M | $91M | · | $91M | $91M | $91M | · | · | $0 | · | · | · | |
| AOCI | $-6M | $3M | $6M | $6M | $6M | $5M | · | · | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $-208M | $-177M | $-249M | $-211M | $-193M | $-211M | · | $-190M | $-173M | $-163M | $10M | $11M | $36M | $-12M | $-11M | $-11M | |
| Liabilities + Equity | $365M | $276M | $84M | $79M | $93M | $100M | · | $91M | $101M | $81M | $126M | $86M | $87M | $101M | $142M | $141M | |
| Shares Outstanding | 7,033,004 | 5,947,947 | 5,497,431 | 5,493,359 | 5,235,377 | 131,721,935 | · | 106,121,250 | 100,015,665 | 94,116,504 | 148,699,982 | 145,811,298 | 141,348,856 | 3,450,000 | 3,450,000 | 3,450,000 |
Nakit Akışı 11
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $946.0K | $944.0K | |
| Stock-based Comp | $6M | $3M | $3M | $3M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $1M | $1M | $1M | $1M | |
| Amort. of Intangibles | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $935.0K | $935.0K | |
| Other Non-cash | · | · | · | $28M | · | · | · | $29M | · | · | · | $18M | · | · | · | · | |
| Operating Cash Flow | $-17M | $8M | $7M | $6M | $3M | $5M | $2M | $9M | $-5M | $6M | $-13M | $-8M | $-725.0K | $-19M | $-22M | $-11M | |
| CapEx | · | · | · | · | $0 | $0 | · | · | $1.0K | $21.0K | · | · | $0 | $7.0K | · | · | |
| Investing Cash Flow | $5M | $-152.0K | $-153.0K | $-395.0K | $-195.0K | $-2M | $-150.0K | $-150.0K | $-167.0K | $-155.0K | $-8.0K | $0 | $0 | $3.0K | $-1M | $-1M | |
| Stock Issued | · | · | · | · | · | $0 | · | $10M | · | $-16M | $15M | $2M | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $10M | · | · | · | $2M | · | · | · | · | |
| Financing Cash Flow | $18M | $-11M | $-9M | $-3M | $-7M | $-4M | $5M | $-11M | $8M | $-39M | $44M | $11M | $426.0K | $17M | $26M | $40M | |
| Net Change in Cash | $4M | $-3M | $-2M | $3M | $-5M | $-2M | $7M | $-2M | $3M | $-33M | $30M | $3M | $-299.0K | $-4M | $-27M | $29M |
Kârlılık 7
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1766.2% | -207.2% | -557.5% | · | -138.0% | · | -179.0% | · | -383.6% | -181.3% | -240.7% | · | · | · | · | |
| Net Margin | · | -2441.5% | -445.1% | -521.2% | · | -30.4% | · | -224.0% | · | -351.2% | -211.8% | -290.6% | · | · | · | · | |
| Pretax Margin | · | -2441.5% | -444.9% | · | · | -30.4% | · | -224.0% | · | -351.2% | -211.8% | -290.5% | · | · | · | · | |
| EBITDA Margin | · | -1766.2% | -207.2% | -537.5% | · | -138.0% | · | -169.5% | · | -383.6% | -181.3% | -230.9% | · | · | · | · | |
| ROA | · | -137.0% | -41.9% | -30.6% | · | -4.9% | · | -27.5% | · | -39.1% | -19.8% | -27.1% | · | -0.11% | 1.1% | -0.57% | |
| ROE | · | 132.8% | 36.9% | 13.0% | · | 2.4% | · | 27.3% | · | 40.7% | 15327.4% | -11439.2% | · | 1.2% | -54.2% | 29.1% | |
| ROIC | · | 105.4% | 8.2% | · | · | 9.4% | · | 10.3% | · | 23.9% | -219.0% | -230.0% | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.0 | 0.1 | 0.1 | · | 0.1 | · | 0.1 | · | 0.1 | 0.7 | 0.5 | · | 0.2 | 1.0 | 12.8 | |
| Quick Ratio | · | 0.0 | 0.1 | 0.1 | · | 0.1 | · | 0.1 | · | 0.1 | 0.6 | 0.4 | · | 0.0 | 0.6 | 3.1 | |
| Interest Coverage | · | · | · | · | · | · | · | -36.7 | · | -75.6 | · | · | · | -569.5 | -173.2 | -42.9 |
Verimlilik 3
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.2 | · | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | · | 1.9 | 1.2 | 0.4 | · | 1.2 | · | 1.3 | · | 1.7 | 2.7 | 3.2 | · | · | · | · | |
| Receivables Turnover | · | 0.5 | 0.4 | 0.2 | · | 0.6 | · | 0.4 | · | 1.2 | 0.9 | 1.1 | · | · | · | · |
Değerleme (TTM) 2
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $40M | $46M | $47M | · | $52M | $50M | $44M | · | $45M | $42M | $37M | · | · | · | · | |
| Net Income TTM | · | $-332M | $-112M | $-92M | · | $-102M | $-124M | $-117M | · | $-71M | $-54M | $-36M | · | $-7M | $-29M | $-9M |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $30M | $57M | $47M | $38M | $31M |
| Brüt Kâr Marjı % | 415.8% | — | — | — | — |
| Faaliyet Kâr Marjı % | -1143.7% | — | -225.6% | -133.1% | — |
| Net Gelir | $-374M | $-73M | $-114M | $-23M | $-88M |
| Seyreltilmiş Hisse Başı Kâr | $-36.48 | $-8.05 | $-1.28 | $-0.17 | $-0.67 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | — | 0.0 | — |
| Cari Oran | 0.1 | — | 0.2 | 0.7 | 2.5 |
| Cari Oran | 0.0 | — | 0.2 | 0.5 | 3.9 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $4M | — | $-21M | $-21M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.